Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Kaleido Biosciences stock | 7.22

Own Kaleido Biosciences stock in just a few minutes.


Fact checked

Kaleido Biosciences, Inc is a biotechnology business based in the US. Kaleido Biosciences shares (KLDO) are listed on the NASDAQ and all prices are listed in US Dollars. Kaleido Biosciences employs 91 staff and has a trailing 12-month revenue of around USD$250,000.

How to buy shares in Kaleido Biosciences

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Kaleido Biosciences. Find the stock by name or ticker symbol: KLDO. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Kaleido Biosciences reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$7.22, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Kaleido Biosciences, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Kaleido Biosciences. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Kaleido Biosciences share price

Use our graph to track the performance of KLDO stocks over time.

Kaleido Biosciences shares at a glance

Information last updated 2020-10-19.
Latest market close USD$7.22
52-week range USD$2.82 - USD$11.89
50-day moving average USD$7.8879
200-day moving average USD$7.0991
Wall St. target price USD$13.25
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-6.237

Buy Kaleido Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Stocks, Mutual funds, ETFs, Forex
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Kaleido Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Kaleido Biosciences price performance over time

Historical closes compared with the close of $7.22 from 2020-11-16

1 week (2020-11-18) 2.27%
1 month (2020-10-23) 4.79%
3 months (2020-08-25) -11.08%
6 months (2020-05-22) 9.23%
1 year (2019-11-25) -13.74%
2 years (2018-11-22) N/A
3 years (2017-11-22) N/A
5 years (2015-11-22) N/A

Kaleido Biosciences financials

Revenue TTM USD$250,000
Gross profit TTM USD$0
Return on assets TTM -49.68%
Return on equity TTM -117.61%
Profit margin 0%
Book value $1.452
Market capitalisation USD$312.8 million

TTM: trailing 12 months

Shorting Kaleido Biosciences shares

There are currently 2.8 million Kaleido Biosciences shares held short by investors – that's known as Kaleido Biosciences's "short interest". This figure is 15.1% up from 2.4 million last month.

There are a few different ways that this level of interest in shorting Kaleido Biosciences shares can be evaluated.

Kaleido Biosciences's "short interest ratio" (SIR)

Kaleido Biosciences's "short interest ratio" (SIR) is the quantity of Kaleido Biosciences shares currently shorted divided by the average quantity of Kaleido Biosciences shares traded daily (recently around 451457.04918033). Kaleido Biosciences's SIR currently stands at 6.1. In other words for every 100,000 Kaleido Biosciences shares traded daily on the market, roughly 6100 shares are currently held short.

However Kaleido Biosciences's short interest can also be evaluated against the total number of Kaleido Biosciences shares, or, against the total number of tradable Kaleido Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Kaleido Biosciences's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Kaleido Biosciences shares in existence, roughly 80 shares are currently held short) or 0.1714% of the tradable shares (for every 100,000 tradable Kaleido Biosciences shares, roughly 171 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Kaleido Biosciences.

Find out more about how you can short Kaleido Biosciences stock.

Kaleido Biosciences share dividends

We're not expecting Kaleido Biosciences to pay a dividend over the next 12 months.

Kaleido Biosciences overview

Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company offers product candidates for the treatment of urea cycle disorders; hepatic encephalopathy; infections caused by multi-drug resistant bacteria; cardiometabolic and liver diseases; and immune oncology. It has a collaboration agreement with Gustave Roussy Cancer Center to develop microbiome metabolic therapies in immuno-oncology; a research collaboration with Washington University School of Medicine to explore the influence of microbiome metabolic therapies on microbial and host physiology and metabolism; and a research collaboration with Janssen to prevent childhood-onset of atopic, immune, and metabolic conditions. The company was founded in 2015 and is headquartered in Lexington, Massachusetts.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site